NCT00903448已完成4 期
Comparison of Prilosec OTC® Versus Prevacid ® for Gastric Acid Suppression
Procter and Gamble1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2009年4月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Mean Percent Time That Gastric pH > 4.0 on Day 5
研究概览
简要总结
The objective of this study is to compare Prilosec OTC® to Prevacid® for gastric acid suppression.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •normal subjects who are age 18-65
- •generally healthy
- •non-childbearing potential females or those using birth control
排除标准
- •history of significant GI disease
- •any significant medical illness
- •history of hypersensitivity, allergy or intolerance to omeprazole, lansoprazole or other proton pump inhibitors
- •currently using GI medications
- •GI disorder or surgery leading to impaired drug absorption
研究组 & 干预措施
A
Experimental
Prilosec OTC
干预措施: Prilosec OTC (omeprazole-magnesium) (Drug)
B
Active Comparator
Prevacid
干预措施: Prevacid (Drug)
结局指标
主要结局
Mean Percent Time That Gastric pH > 4.0 on Day 5
时间窗: 24 hours
for 24 hours starting Day 5 for each period
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Comparison of Prilosec OTC® Versus Zegerid® for Gastric Acid SuppressionNormal Healthy Subject PopulationNCT00808769Procter and Gamble30
Unknown
4 期
Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic UlcerPeptic UlcerNCT00471029Pamela Youde Nethersole Eastern Hospital20
终止
3 期
Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic OmeprazoleGastric AcidNCT00542347Queen's University20
已完成
4 期
Effect of Prevacid on Prostaglandin Levels in Patient With Stress UlcerStomach UlcerNCT00239551Emory University30
已完成
4 期
Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg poHealthyNCT00206050AstraZeneca40